Cart
sales@molnova.com
GSK3i XIII
CAS No. 404828-08-6
GSK3i XIII( GSK3i-XIII | GSK3iXIII | GSK3 inhibitor XIII )
Catalog No. M24364 CAS No. 404828-08-6
GSK3i XIII is a GSK-3 ATP-binding site inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 130 | In Stock |
|
| 5MG | 117 | In Stock |
|
| 10MG | 176 | In Stock |
|
| 25MG | 295 | In Stock |
|
| 50MG | 420 | In Stock |
|
| 100MG | 591 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK3i XIII
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3i XIII is a GSK-3 ATP-binding site inhibitor.
-
DescriptionGSK3i XIII is a GSK-3 ATP-binding site inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK3i-XIII | GSK3iXIII | GSK3 inhibitor XIII
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number404828-08-6
-
Formula Weight301.35
-
Molecular FormulaC18H15N5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC1=CC(=NN1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.James TF, Nenov MN, Wildburger NC, Lichti CF, Luisi J, Vergara F, Panova-Electronova NI, Nilsson CL, Rudra JS, Green TA, Labate D, Laezza F. The Nav1.2 channel is regulated by GSK3. Biochim Biophys Acta. 2015 Apr;1850(4):832-44. doi: 10.1016/j.bbagen.2015.01.011. Epub 2015 Jan 20. PubMed PMID: 25615535; PubMed Central PMCID: PMC4336163.
molnova catalog
related products
-
5-Bromoindole
5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
-
GSK-3 inhibitor 4
GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5).
-
BRD0209
BRD0209 is a highly selective, potent, reversible, ATP-competitive GSK3 inhibitor with IC50 of 19 nM/5 nM for GSK3α/GSK3β respectively.
